OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 104 filers reported holding OREXIGEN THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 5.73 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $505,000 | -19.1% | 293,400 | -0.7% | 0.00% | 0.0% |
Q3 2015 | $624,000 | -56.7% | 295,600 | +1.5% | 0.00% | -66.7% |
Q2 2015 | $1,442,000 | -39.8% | 291,300 | -4.8% | 0.00% | -25.0% |
Q1 2015 | $2,397,000 | +44.3% | 306,100 | +11.7% | 0.00% | +33.3% |
Q4 2014 | $1,661,000 | +31.7% | 274,100 | -7.4% | 0.00% | +50.0% |
Q3 2014 | $1,261,000 | +7.8% | 295,900 | +56.2% | 0.00% | 0.0% |
Q2 2014 | $1,170,000 | +92.4% | 189,400 | +102.4% | 0.00% | +100.0% |
Q1 2014 | $608,000 | +247.4% | 93,600 | +213.0% | 0.00% | – |
Q2 2013 | $175,000 | – | 29,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management I, LLC | 1,250,000 | $8,125,000 | 5.71% |
Rock Springs Capital Management LP | 830,000 | $5,395,000 | 1.24% |
First Light Asset Management, LLC | 195,359 | $1,270,000 | 0.90% |
Palo Alto Investors LP | 3,338,048 | $21,698,000 | 0.90% |
Rhenman & Partners Asset Management AB | 329,199 | $2,140,000 | 0.64% |
NEA Management Company, LLC | 1,935,300 | $12,579,000 | 0.62% |
PFM Health Sciences, LP | 5,129,129 | $33,339,000 | 0.60% |
Sivik Global Healthcare LLC | 124,145 | $807,000 | 0.50% |
QVT Financial LP | 1,322,729 | $8,598,000 | 0.49% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 433,657 | $2,819,000 | 0.41% |